Finance

Beta
Lists
COF:FRA
Cofinimmo SA
€78.20
-1.14%
(-0.90) 1D
Jun 4, 8:04:50 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for COF...
Open
€78.20
High
€78.20
Low
€78.20
Mkt. cap
3.02B
Avg. vol.
0.00
Volume
0.00
Dividend
4.65%
Quarterly dividend
€0.91
Ex-dividend date
May 19, 2026
P/E ratio
14.69
52-wk high
€93.10
52-wk low
€69.75
EPS
€5.32
No. of employees
145
Open
€78.20
High
€78.20
Low
€78.20
Mkt. cap
3.02B
Avg. vol.
0.00
Volume
0.00
Dividend
4.65%
Quarterly dividend
€0.91
Ex-dividend date
May 19, 2026
P/E ratio
14.69
52-wk high
€93.10
52-wk low
€69.75
EPS
€5.32
No. of employees
145
News stories
From sources across the web
Profile
Cofinimmo is the foremost listed Belgian real estate company specialising in rental property. The company owns a property portfolio spread across nine European countries with a value of approximately 6.2 billion EUR by 2023. It involves healthcare properties, offices, and property of distribution networks. The healthcare real estate portfolio has a value of approximately 4.6 billion EUR. As an independent company applying the highest standards of corporate governance and sustainability, Cofinimmo offers tenant services and manages its portfolio through a team of approximately 155 employees in Brussels, Paris, Breda, Frankfurt and Madrid. Cofinimmo is listed on Euronext Brussels and is part of the BEL20 index. The company benefits from the REIT regime in Belgium, in France and in the Netherlands. Its activities are supervised by the Financial Services and Markets Authority, the Belgian regulator. Wikipedia
About Cofinimmo SA
CEOJean-Pierre Hanin
Employees145
Founded1983
Headquarters-
SectorReal estate investment trust
Websitecofinimmo.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
90.08M
84.16M
120.77M
88.10M
Cost of goods sold
6.14M
120.00K
78.57M
6.60M
Cost of revenue
6.14M
120.00K
78.57M
6.60M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10.87M
9.54M
-19.21M
9.59M
Operating expense
10.62M
9.45M
-5.02M
9.63M
Total operating expenses
16.75M
9.57M
73.54M
16.23M
Operating income
73.32M
74.58M
47.22M
71.87M
Other non operating income
12.01M
-12.67M
17.77M
-316.00K
EBT including unusual items
49.37M
61.23M
47.66M
56.07M
EBT excluding unusual items
70.66M
64.57M
45.47M
65.25M
Income tax expense
2.27M
1.55M
2.11M
1.67M
Effective tax rate
4.60%
2.53%
4.43%
2.98%
Other operating expenses
-232.00K
-111.00K
14.19M
43.00K
Net income
47.98M
57.95M
43.27M
53.51M
Net profit margin
53.26%
68.86%
35.83%
60.74%
Earnings per share
1.68
1.69
1.57
1.63
Interest and investment income
4.75M
4.66M
2.70M
3.22M
Interest expense
-20.55M
-
-22.51M
-9.19M
Net interest expenses
-15.81M
4.66M
-19.81M
-5.97M
Depreciation and amortization charges
-
-
-
-
EBITDA
73.42M
74.68M
47.29M
71.95M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer